BRIACELL THERAPEUTICS CORP. Share-based Payment Arrangement, Expense
BRIACELL THERAPEUTICS CORP. (BCTX) reported Share-based Payment Arrangement, Expense of $392.21 thousand for the 3-month period ending 2024-04-30, per its 10-Q filed 2024-06-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2024-06-14
- BRIACELL THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2024-04-30 was $392.21K, a 39.48% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2024-01-31 was $500.15K, a 87.43% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2023-10-31 was $533.82K, a 51.99% decline year-over-year.
- BRIACELL THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2023-04-30 was $281.19K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2024-04-30 | $392.21K 10-Q · filed 2024-06-14 | $892.37K derived: sum of 2 quarters · filed 2024-06-14 | $1.43M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $500.15K 10-Q · filed 2024-03-18 | $1.03M 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $533.82K 10-Q · filed 2023-12-14 | ||
| 2023-04-30 | $281.19K 10-Q · filed 2024-06-14 | $548.03K derived: sum of 2 quarters · filed 2024-06-14 | $1.66M 10-Q · filed 2024-06-14 |
| 2023-01-31 | $266.84K 10-Q · filed 2024-03-18 | $1.38M 10-Q · filed 2024-03-18 | |
| 2022-10-31 | $1.11M 10-Q · filed 2023-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |